The second question addressed in this study was whether podocyte-specific deletion of Myh9 on the C57BL/6 background results in predisposition to glomerulosclerosis in general, perhaps from a “weakened” podocyte, or whether the predisposition is specific to Adriamycin injury. Here, MYH9 is linked to glomerulosclerosis.